Manufacturing process for a three-dimensional medical device and the resulting medical device

The method of wetting and conforming acellular biological matrices addresses the inefficiencies of current shaping methods by allowing flexible and malleable shaping without supports, producing three-dimensional medical devices efficiently and cost-effectively.

FR3110077B1Active Publication Date: 2024-12-06PH TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
FR2020004641
Authority / Receiving Office
FR · FR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-05-12
Publication Date
2024-12-06
Estimated Expiration
2040-05-12

AI Technical Summary

Technical Problem

Current techniques for manufacturing three-dimensional medical devices from acellular biological matrices require supports or complex processes like perforation, cutting, suturing, or gluing to maintain shape, which are cumbersome and inefficient.

Method used

A method involving wetting the acellular biological matrix with a liquid to make it flexible and malleable, followed by conforming it into a three-dimensional shape without the need for supports or additional processes like perforation or gluing, using vacuum forming, wet molding, or pressing.

Benefits of technology

Enables the easy, quick, and cost-effective production of three-dimensional medical devices that can be used as implants, maintaining biological compatibility and mechanical resistance, while eliminating the need for complex shaping processes.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a method for manufacturing a three-dimensional medical device from an acellular biological matrix, characterized in that it comprises at least the following steps: a) wetting an acellular biological matrix with a liquid, and b) shaping the wetted acellular biological matrix so that it takes on a three-dimensional form. The invention also relates to the resulting three-dimensional medical device and its use as an implant.
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: Method for manufacturing a three-dimensional medical device and medical device obtained

[0001] The invention relates to a method for obtaining a three-dimensional medical device from an acellular biological matrix, as well as the medical device obtained and its use in particular as an implant.

[0002] Many surgical applications require the reinforcement of soft tissues and / or the replacement of lost anatomical sections, such as breast reconstructions.

[0003] These interventions require the addition of medical devices combining mechanical resistance, flexibility and biological compatibility.

[0004] For this purpose, biological matrices are increasingly used for the manufacture of medical devices due to their biological compatibility. Indeed, in breast reconstruction after a mastectomy or as part of another aesthetic breast reconstruction surgery, many implants include an acellular dermal matrix that covers the implant / prosthesis and is connected to the pectoralis major muscle, thus avoiding the need to stretch the skin and muscles before implant placement. In addition, such a matrix helps support the tissues and their regeneration.

[0005] However, for surgical indications requiring a particular three-dimensional shape, the use of an acellular biological matrix is ​​only possible in the presence of a support allowing the biological matrix to be maintained in three dimensions. In addition, current techniques are complex and require either perforating the acellular biological matrix to allow it to take on a three-dimensional shape, or cutting out elements of the matrix to assemble them by suturing, gluing, etc.

[0006] There is therefore a need for biological implants comprising an acellular biological matrix which do not require the presence of a support allowing the three-dimensional maintenance of the biological matrix nor the implementation of techniques involving perforation or cutting, suturing or gluing.

[0007] The objective of the invention is to meet this need.

[0008] To this end, the invention relates to a method for manufacturing a three-dimensional medical device from an acellular biological matrix, characterized in that it comprises at least the succession of the following steps: a / wetting an acellular biological matrix with a liquid, and b / shaping the wetted acellular biological matrix so that it takes a three-dimensional shape.

[0009] Advantageously, the wetting step makes the acellular biological matrix flexible and malleable, allowing it to be shaped in three dimensions. Thus, the method makes it possible to obtain easily, quickly and at low cost, a three-dimensional medical device, usable as an implant, without the need for support allowing the biological matrix to be maintained in three dimensions, nor for perforation of the biological matrix.

[0010] The invention therefore also relates to a three-dimensional (non-planar) medical device comprising at least one acellular biological matrix shaped in three dimensions, as well as its use as an implant.

[0011] Other characteristics and advantages will emerge from the detailed description of the invention which follows.

[0012] Definitions

[0013] By “acellular” biological matrix within the meaning of the invention is meant a biological matrix in which the cellular elements have been eliminated by a decellularization process with the aim of destroying and / or removing the cells and their components from the extracellular matrix of the biological matrix while maintaining its structure and properties. Indeed, for a biological matrix to be able to be implanted in a recipient, it must be decellularized so as to reduce its immunogenicity.

[0014] By “Allograft” within the meaning of the invention is meant a biological matrix, a graft, originating from a donor belonging to the same biological species as the recipient.

[0015] By "conforming" or "shaping" within the meaning of the invention is meant obtaining a shape similar to that of another object considered as a model, as a reference point.

[0016] By “Implant” within the meaning of the invention is meant a medical device used in surgery.

[0017] For the purposes of the invention, the term “biological matrix” means a biomaterial derived from the human or animal species.

[0018] For the purposes of the invention, the term "P4HB" means a particular PHA which stands for Poly-4-hydroxybutyrate. It is a homopolymer of a 4-hydroxybutyrate unit.

[0019] “Peel test” is used herein with reference to a test for determining the strength adhesion between 2 materials. Each material is placed in pneumatic jaws at a given pressure then separated at constant speed as specified in the examples.

[0020] By “PHAs” in the sense of the invention we mean polyhydroxyalkanoates which are biodegradable polyesters.

[0021] By “three dimensions” we mean any object, in particular any medical device, including any non-flat implant.

[0022] For the purposes of the invention, the term “solution” means a homogeneous mixture resulting from the dissolution of one or more solute(s) in a solvent.

[0023] By "Suture Retention Force" or "Suture Retention Strength" within the meaning of the invention is meant a test making it possible to determine the force (N) necessary to pull a suture out of a specimen.

[0024] By "Uniaxial tensile strength" ("uniaxial tensile strength") within the meaning of the invention is meant a test for determining the tension before rupture of the specimen tested. The properties measured are Ultimate Tensile Strength (maximum tensile strength), breaking force and elongation at rupture.

[0025] For the purposes of the invention, “Viscosity” means a property of resistance to the flow of a fluid for a flow without turbulence.

[0026] For the purposes of the invention, the term “Xenograft” means a biological matrix, a graft, originating from a donor belonging to a biological species different from that of the recipient. Detailed description of the invention

[0027] I. Method for manufacturing a three-dimensional medical device

[0028] According to a first aspect, the invention relates to a method for manufacturing a three-dimensional medical device from an acellular biological matrix.

[0029] Acellular biological matrices include a large class of biomaterials extracted from grafts of various origins.

[0030] Preferably, the biological matrix in the medical device according to the invention is of human or non-human animal origin (Allograft or Xenograft).

[0031] According to a particularly suitable embodiment, it is a biological matrix chosen from biological matrices of non-human animal origin chosen from biological matrices of porcine, bovine, equine, caprine, fish origin and their mixtures.

[0032] The biological matrix according to the invention can be chosen from all animal and / or human biological matrices, preferably from one of the following biological matrices: dermis, intestinal submucosa, aorta, bladder, amniotic membrane, peritoneum, pericardium, dura mater, tendons, cartilage and mixtures thereof.

[0033] The biological matrix of the three-dimensional medical device according to the invention is acellular. There are many known methods for obtaining an acellular biological matrix. The methods used may be enzymatic and / or based on chemical solutions and / or relying on mechanical methods. The method used must be a method for obtaining an acellular biological matrix capable of being used in surgery, particularly for soft tissue reconstruction.

[0034] The acellular biological matrix according to the invention is preferably an acellular biological matrix which has at least one of the following characteristics, even more preferably all of them: - “Uniaxial Tensile Strength” greater than or equal to 5N / mm2 for a 5 mm x 50 mm specimen with a thickness taken into account in the calculation. Each end is attached in pneumatic jaws lengthwise 1 cm from each edge. The edge separation speed is 30 mm / min. “Uniaxial Tensile Strength” is reported by dividing the maximum force (N) / (5 (mm) x thickness (mm)). - “Suture Retention Force” greater than or equal to 5N for a 1cm x 1cm specimen using an appropriate suture (type 4-0 polypropylene) threaded 3 mm from the edge of the specimen in its center, the opposite side being clamped in a pneumatic jaw at approximately 5 mm. Both ends of the suture thread are clamped in the lower jaw. The jaw separation speed is 20rnm / min. The maximum force (N) is retained.

[0035] Preferably, the biological matrix used has the specifications defined in the applicable standards (“USP official monographs” latest version, ASTM) according to the type of biological matrix used.

[0036] The acellular biological matrix used for implementing the method according to the invention can be of various shapes. Preferably it: - is dry, preferably it has a residual humidity level of between 10% and 18%, and / or - has a surface appearance improving the adhesion of at least one polymer, in particular the adhesion of at least one solution of polymer(s).

[0037] The acellular biological matrix used for implementing the method according to the invention can have different shapes (round, square, circular, irregular, etc.), flat or in relief, with channels, with one of the textured surfaces, be of regular or irregular thickness.

[0038] The method according to the invention for manufacturing a three-dimensional medical device from an acellular biological matrix comprises at least the following succession of steps: a / wetting an acellular biological matrix with a liquid, preferably water, and b / conform the wet acellular biological matrix so that it takes on a three-dimensional shape.

[0039] Step a / which consists of wetting the acellular biological matrix aims to make said acellular biological matrix flexible and malleable so as to then allow it to be shaped.

[0040] Preferably, step a / consisting of wetting the acellular biological matrix is ​​carried out by soaking the acellular biological matrix in a volume of water allowing its immersion. Preferably, the soaking is carried out for a period of 30 seconds to 20 minutes.

[0041] The water can be of different qualities (pyrogenic, purified water, etc.). According to a particularly suitable embodiment, step a / is carried out with pyrogenic water.

[0042] Preferably, during the wetting step a / the acellular biological matrix becomes gray, more particularly it changes from white to gray.

[0043] After wetting, the acellular biological matrix can be shaped in three dimensions. Preferably, the shaping step b / is carried out by vacuum forming and / or wet molding and / or pressing.

[0044] In the case of conforming by vacuum forming, the matrix is ​​placed on the desired shape or mold. The assembly is then placed in a system allowing the matrix to be held on the mold, the shape for the time necessary for the vacuum forming treatment. Said system may be composed of a food-type vacuum bag of variable thicknesses (80 to 200 microns) and / or a solid or perforated counter-shape or simply having sections similar to the shape (base) held on the formed matrix by any means during and after treatment. The assembly: "shape + formed matrix" and holding system are then placed in a drying system (freeze-dryer, oven, etc.). In a preferred embodiment, the wet biological matrix is ​​placed on a perforated form (or in a mold). The assembly is then placed in a vacuum bag for treatment in a Henkelman-type vacuum machine. The vacuum is then created over a cycle of 10 to 60 seconds between -1 bar and -2 bars, preferably -1 bar. The treatment time / vacuum rate combination can be assessed by those skilled in the art depending on the desired result. The matrix is ​​then shaped and maintained in this state by the vacuum bag. Preferably, a drying method that does not denature the collagen by excessively high temperatures is preferred. The vacuum bag containing the shape and the shaped matrix is ​​then placed in a freeze-dryer for drying. Preferably, said bag can be placed in a freezer at -40°C for freezing. After freezing, the shaped matrix and the shape are placed in a freeze-dryer for drying. The freeze-drying cycles for biological matrices are known to those skilled in the art. The matrix can also be removed from the bag and placed with the shape in a freeze-dryer for drying; the freeze-drying cycle then includes a freezing step.

[0045] In the case of pressing, the die is placed in a Short Nose type press An evolution of Maugin. The machine is first equipped with a mold on the lower part and a counter-form on the piston. The operation then consists of pressing the biological matrix between the two elements for a defined time (between 30s and 120s) and a chosen pressure (between 50 bars and 200 bars). A temperature can also be regulated (between 50°C and 150°C). The matrix thus formed is then dried on a suitable form.

[0046] In the case of wet molding, the die is placed on a form and then shaped on the form using a pusher. The part is held on the form by mechanical fasteners (staples, etc.).

[0047] According to a variant of the invention, the method of manufacturing a medical device according to the invention also comprises: - before or after step a / or before or after step b / , a step of preparing the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, and - before or after a / or before or after step b / , a step of partial or total coating of the acellular biological matrix with a solution comprising at least one polymer. The coating step only occurs after the step of preparing the acellular biological matrix so as to allow adhesion to said acellular biological matrix of the solution comprising at least one polymer used for the coating.

[0048] According to a first embodiment of this variant, the method of manufacturing a medical device according to the invention comprises at least the succession of the following steps: -1 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 2 / partially or totally coat the acellular biological matrix with a solution comprising at least one polymer, - 3 / wet the acellular biological matrix with a liquid, - 4 / conform the wet and coated acellular biological matrix so that it takes on a three-dimensional shape.

[0049] According to a second embodiment of this variant, the method of manufacturing a medical device according to the invention comprises at least the succession of the following steps: -1 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 2 / wet the acellular biological matrix with a liquid, - 3 / partially or totally coating the acellular biological matrix with a solution comprising at least one polymer, - 4 / conform the wet and coated acellular biological matrix so that it takes on a three-dimensional shape.

[0050] According to a third embodiment of this variant, the method of manufacturing a medical device according to the invention comprises at least the succession of the following steps: -1 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 2 / wet the acellular biological matrix with a liquid, - 3 / conform the wet acellular biological matrix so that it takes on a three-dimensional shape. - 4 / partially or totally coat the acellular biological matrix with a solution comprising at least one polymer.

[0051] According to a fourth embodiment of this variant, the method of manufacturing a medical device according to the invention comprises at least the succession of the following steps: - 1 / wet the acellular biological matrix with a liquid, - 2 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 3 / partially or totally coat the acellular biological matrix with a solution comprising at least one polymer. - 4 / conform the wet and coated acellular biological matrix so that it takes on a three-dimensional shape.

[0052] According to a fifth embodiment of this variant, the method of manufacturing a medical device according to the invention comprises at least the succession of the following steps: - 1 / wet the acellular biological matrix with a liquid, - 2 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 3 / conform the wet acellular biological matrix so that it takes on a three-dimensional shape. - 4 / partially or totally coat the acellular biological matrix with a solution comprising at least one polymer.

[0053] According to a sixth embodiment of this variant, the method of manufacturing a three-dimensional medical device according to the invention comprises at least the succession of the following steps: - 1 / wet the acellular biological matrix with a liquid, - 2 / conform the wet acellular biological matrix so that it takes on a three-dimensional shape. - 3 / prepare the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, - 4 / partially or totally coat the acellular biological matrix with a solution comprising at least one polymer.

[0054] Preferably, the step of preparing the cellular biological matrix consists of a chemical and / or mechanical and / or electrochemical and / or physical surface treatment. This may be, for example, a treatment by abrasion and / or milling and / or microtexturing and / or laser and / or UV. The acellular biological matrix, before coating, must in fact be prepared in such a way as to allow the adhesion of a solution of polymer(s).

[0055] In a preferred embodiment, the acellular biological matrix before coating and / or after coating, must be dry or dried so as to have a residual moisture content of the order of 10% to 18%. The residual moisture content is preferably measured using a desiccator of the Halogen Moisture Analyzer type from Mettler Toledo.

[0056] A drying technique used is preferably that of Loss on Drying described in USP 41 (scaffold bovine dermis): -1- an empty aluminum cup is positioned in the device and the tare is carried out, -2- the cup is filled with a sample of 1.0 g + / - 0.2 g cut into pieces of 4 mm2, -3- the heating program at 130°C is launched -4- when the weight no longer varies over a given time, the result is displayed in %.

[0057] Another conventional oven drying method can also be used. In this context, an aluminum cup previously weighed empty is filled with a sample of 5.0 g + / - 0.2 g cut into 4 mm2 pieces. The whole is placed at 100°C for 16 hours. The whole is then weighed and the “loss on drying” is calculated: - dry matter % = [(weight of dry extract + cup (g) - weight of cup (g)) / g of sample] x 100 - humidity % = 100 - dry matter %.

[0058] The prepared biological matrix is ​​then used for coating with a polymer solution.

[0059] The polymer(s) used to coat the acellular biological matrix in the method according to the invention are preferably chosen from the following polymers: poly(glycolides), poly(lactide-co-glycolides); poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acids), polycaprolactones, poly(orthoesters), polyanhydrides, poly(phosphazenes), polyhydroxyalkanoates (including in particular P4HB and poly-3-hydroxybutyrate-co-3-hydroxy valerate (PHBV)), polyesters, poly(lactide-co-caprolactones), polycarbonates, tyrosine polycarbonates, polyamides, polyesteramides, poly(dioxanones), poly(alkylene alkylates), polyethers, polyvinyl pyrrolidones or PVP, polyurethanes, polyetheresters, polyacetals, polycyanoacrylates, poly(oxyethylene) / poly(oxypropylene) copolymers, polyacetals, polyketals, poly-phosphates, polyphosphoesters, polyalkylene oxalates, polyalkylene succinates, poly(maleic acids), chitin, chitosan, and mixtures thereof.

[0060] Preferably, the solution comprising at least one polymer has been previously obtained by solubilizing the dry polymer(s) in at least one solvent, preferably at least one polar solvent.

[0061] The polymer(s) must in fact preferably be converted into a solution suitable for coating using the appropriate solvent.

[0062] When the polymer is a PHA and in particular P4HB and / or one of its copolymers, the solvent is preferably chosen from the following polar solvents: dichloromethane, chloroform, tetrahydrofuran, dioxane, acetone and their mixtures.

[0063] In a preferred embodiment, the P4HB is solubilized in an acetone solution, preferably in a ratio of 5% to 25% (w / w). The respective quantities are brought together, the whole is heated and maintained at a temperature below the boiling point of acetone (approximately 56°C) until the P4HB is completely dissolved and the desired viscosity of at least 10%, more preferably 15% and even more preferably 20% (w / w) is obtained.

[0064] Preferably, after solubilization of the polymer(s) in a solvent, the polymer solution is degassed and / or debubbled to purge the mixture of air bubbles. Preferably, the solution is placed under vacuum (minimum -1 bar) for the time necessary for complete degassing / debubbling.

[0065] The step of coating the acellular biological matrix with a solution of polymer(s) is preferably carried out at a temperature lower than or equal to the denaturation temperature of the collagen. In a particularly suitable manner, the coating is carried out at a temperature between 10 and 60°C, preferably between 10 and 50°C, even more preferably between 20 and 50°C.

[0066] The coating can be carried out by any suitable means, preferably by solvent casting (coating by casting), spray coating (coating by vaporization), dip coating (coating by immersion).

[0067] Advantageously, the method according to the invention allows the direct application of a solution of polymer(s) at the desired concentration on a previously prepared acellular biological matrix and it is not necessary to first manufacture a film or a sheet of polymer to then place it on the support in order to allow the elements to adhere to each other by heating.

[0068] When carried out by "solvent casting", the coating can be carried out with different technologies: knife, double side, commabar, case knife, engraved roller, 2 roller, 3 roller combi, micro roller, 5 roller, reverse roller, rotary screen, dipping, slot die, curtain coating, hotmelt slot die. The simplest method is based on the use of an Elcometer type casting knife. The biological matrix is ​​placed on a table. Depending on the desired thickness and the surface to be treated, the necessary quantity of polymer solution is placed on the acellular biological matrix. The Gardener Knife is then moved over the acellular biological matrix to uniformize the coating on the implant.The Gardener Knife has been previously adjusted to a certain height. For the purpose of automating the operation, a coating machine can be used. The polymer solution(s) is pumped through a slot die to be applied to the moving planar biological implant. In a preferred embodiment, the width of the slot die is 600 mm, the implant advancement speed is 1 - 10 m / min. The pumping speed, the advancement speed, the width of the slot die and the concentration of the solution can be adjusted to obtain the implant with a coating of the desired thickness and width.

[0069] When the coating is carried out by "spray coating" or spraying, the polymer solution(s) is pumped to a nozzle which projects droplets onto the surface to be treated. This technique is particularly advantageous for the treatment of biological matrices which have 3D shapes (example: biological implant having a hemispherical, ovoid, tubular shape, in the shape of anatomical breast implants, etc.).

[0070] When the coating is carried out by "Dip coating" (immersion coating), or by dipping, the part to be treated is dipped in a dissolved, melted, softened or fluidized powder material in order to cover it with a layer of this material. This technique is particularly advantageous for the treatment of raised and flat biological implants.

[0071] After coating, the medical device obtained is composed of a layer of biological matrix partially or totally coated with at least one polymer in solution, and the whole being then dried and then preferably pressed to obtain a uniform thickness.

[0072] In a preferred embodiment, the acellular biological matrices coated with the polymer solution(s) are placed in an oven or furnace or enclosure. heats to allow complete evaporation of the solvent. At a temperature between 0°C and 50°C, between 15 and 40°C, preferably 30°C plus or minus 5°, so as to avoid excessively rapid evaporation and deformation of the biological matrix.

[0073] IL Three-dimensional medical device and uses

[0074] According to a second aspect, the invention also specifically relates to a three-dimensional medical device, capable of being obtained by implementing the method according to the invention, comprising at least one acellular biological matrix shaped in three dimensions.

[0075] Advantageously, the three-dimensional medical device according to the invention does not comprise a support for maintaining the acellular biological matrix in three dimensions, said biological matrix having been shaped in three dimensions by shaping methods carried out on the previously wetted acellular biological matrix (preferably immersed in water).

[0076] Preferably, the three-dimensional medical device according to the invention comprises at least one acellular biological matrix partially or totally covered by at least one layer comprising at least one polymer.

[0077] The three-dimensional medical device according to the invention may comprise one or more acellular biological matrices, one or more layers of polymer(s) and possibly other constituents. The three-dimensional medical device according to the invention may comprise, for example, at least one acellular biological matrix partially or totally covered by at least two layers comprising at least one polymer.

[0078] According to a particular embodiment, the three-dimensional medical device consists exclusively of an acellular biological matrix partially or totally covered by a layer comprising at least one polymer.

[0079] According to another particular embodiment, the three-dimensional medical device is constituted exclusively by an acellular biological matrix partially or totally covered by two layers comprising at least one polymer.

[0080] The presence of the polymer(s) in the three-dimensional medical device according to the invention allows optimal reinforcement during tissue reconstruction supported by the biological matrix, even in the event of infection. Indeed, the presence of at least one polymer with the acellular biological matrix makes it possible to make the biological matrix resistant to infections, while retaining the qualities of the biological matrix in terms of mechanical strength, flexibility and biological compatibility. It can thus be used for medical applications, particularly in surgery.

[0081] The polymer present in the three-dimensional medical device according to the invention may be any type of polymer suitable for use as a medical device and in particular as an implant, in particular as a biological implant, in particular as a surgical implant or surgical biological implant.

[0082] The polymer(s) used present in the three-dimensional medical device according to the invention are preferably chosen from the following polymers: poly(glycolides), poly(lactide-co-glycolides); poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acids), polycaprolactones, poly(orthoesters), polyan-hydrides, poly(phosphazenes), polyhydroxyalkanoates (including in particular P4HB and poly-3-hydroxybutyrate-co-3-hydroxy valerate (PHBV)), polyesters, poly(lactide-co-caprolactones), polycarbonates, tyrosine polycarbonates, polyamides, polyesteramides, poly(dioxanones), poly(alkylene alkylates), polyethers, polyvinyl pyrrolidones or PVP, polyurethanes, polyetheresters, polyacetals, polycyanoacrylates, poly(oxyethylene) / poly(oxypropylene) copolymers, polyacetals, polyketals, poly-phosphates, polyphosphoesters, polyalkylene oxalates, polyalkylene succinates, poly(maleic acids), chitin, chitosan, and their mixtures.

[0083] According to a particularly suitable embodiment, the three-dimensional medical device according to the invention comprises at least one PHA and even more preferably at least one PHA chosen from P4HB, P4HB copolymers and their mixtures. PHAs constitute a family of materials produced by numerous microorganisms. Mention may be made, for example, of US patent 6,316,262 from the company Metabolix, Inc. of Cambridge MA, USA, which describes a method for obtaining a biological system for producing polyhydroxyalkanoate polymers containing 4-hydroxy acids. US patents 6,245,537, US 6,623,748, US 7,244,442 and US 8,231,889 also describe methods for producing PHAs suitable for medical use and for medical devices according to the invention.

[0084] Preferably, PHA and in particular P4HB and / or its copolymers have a low level of endotoxins, in particular they allow for a level of less than 20 EU per medical device.

[0085] The polymer layer(s) may comprise one or more channels which allow the incorporation, during use in surgery, of elements promoting optimal reconstruction of the tissues in which the device is used as an implant (PRP, stem cells, antibiotics, etc.). These channels may be circular or non-circular. They preferably have an internal surface area of ​​between 0.007 mm2 and 0.8 mm2. They may be obtained by printing a shape in the biological matrix by pressing before coating the biological matrix. The shape is then removed after coating and drying.

[0086] The medical device according to the invention is preferably used as a biological implant, in particular as a surgical implant or surgical biological implant. According to one variant, it is an implant for breast reconstruction.

[0087] In particular and in a non-limiting manner, the three-dimensional medical devices according to the invention can be used for the following applications: repair, regeneration and replacement of soft and hard tissues, healing device, bandage, patch, dressing, burn dressing, ulcer dressing, skin substitute, hemostatic, tracheal reconstruction device, organ salvage device, dural substitute, dural patch, guide nerve, nerve regeneration or repair device, hernia repair device, hernia mesh, hernia plug, temporary wound or tissue support device, tissue engineering scaffold, guided tissue repair / regeneration device, mesh fixation devices, anti-adhesion membrane, barrier adhesion, tissue separation membrane, retention membrane, sling, pelvic floor reconstruction device, urethral suspension device,urinary incontinence treatment device, bladder repair device, inflation or filling device, rotator cuff repair device, meniscus repair device, meniscus regeneration device, guided tissue regeneration membrane for periodontal tissues, anastomosis device, cell-seeded device, cell encapsulation device, controlled release device, drug delivery device, plastic surgery device, breast lift device, mastopexy device, breast reconstruction device, breast augmentation device, breast reduction device, breast reconstruction devices after mastectomy with or without breast implants, rhinoplasty device.

[0088] The invention is now illustrated by examples.

[0089] III. Examples

[0090] Example 1: wetting and shaping An acellular dermal matrix is ​​wetted as follows: it is immersed in a volume of type 2 purified water for 15 min. It is then placed on an anatomical breast form itself screwed onto a perforated tray. The dermal matrix is ​​fixed to the edges of the tray by mechanical fasteners (staples, peripheral frame, etc.). The assembly is placed in an 80 micron vacuum bag. The treatment is carried out by a Henkelman Marlin type machine. The vacuum treatment is carried out at - Ibar. After treatment, the assembly is placed in a freezer at -40 °C. Once frozen, the contents are removed from the bag and then placed in a freeze dryer for drying. Preferably the matrix is ​​sterilized. The acellular biological matrix thus shaped in three dimensions can be used as a medical device, particularly as an implant, particularly in surgery.

[0091] Example 2: wetting and shaping A dermal matrix is ​​wetted as follows: it is immersed in a volume of pyrogen-free water for 3 min. It is then placed in a Short Nose Evolution type press from Maugin. Pressure is exerted at 100 bars for 30 seconds and at a temperature of 100°C. The matrix thus treated is placed in an oven for drying at 40°C overnight. After drying, the implants thus formed can be pressed to standardize the thickness in a hydraulic press equipped with the appropriate form and counter-form. The space between the two is adjusted to control the desired thickness. The pressing time varies between 30s and 60s and the pressure between 50 bars and 200 bars. The acellular biological matrix thus shaped in three dimensions can be used as a medical device, particularly as an implant, particularly in surgery.

[0092] Example 3: treatment of the acellular biological matrix A dry, flat acellular dermal matrix (residual moisture content between 10% and 18%) is placed on a numerically controlled machine tool. A 5 mm diameter carbide burr is mounted on the machine tool. A rotation speed of 20,000 to 40,000 rpm is used with a feed rate of 2 m / min. The depth is variable depending on the desired final thickness. Surfacing can be total or only concern a part of the implant in order to delineate shapes. The matrix is ​​then coated with a solution of polymer(s), preferably according to example 6. The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0093] Example 4: treatment of the acellular biological matrix A dry, flat acellular dermal matrix (residual moisture content between 10% and 18%) is placed on a brushing / carding machine. The implant surface is then treated with cards of the desired diameter (e.g. 105 mm) made of metal wires (e.g. 0.2 mm diameter). The matrix is ​​then coated with a solution of polymer(s). The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0094] Example 5: treatment of the acellular biological matrix A dry acellular dermal matrix (residual humidity level between 10% and 18%) is treated with a high-frequency electric field such as Telea Biotech (4-64 MHz) in order to create cavities and / or perforations of 0.6 mm in diameter. The matrix is ​​then coated with a solution of polymer(s). The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0095] Example 6: treatment of the acellular biological matrix An acellular dermal matrix is ​​processed as specified in Example 3. A 2 mm carbide bur is mounted on the machine tool to cut sinusoidal channels in the matrix along the length of the matrix. Speed ​​and feed are similar to Example 1. The channels are repeated at regular intervals across the width to cover part or all of the implant. The depth of the channels is a function of the desired final diameter. In another embodiment, an impression can be made to press the channels into the matrix. The matrix is ​​then coated with a solution of polymer(s). The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0096] Example 7: example of a “solvent casting” coating process An acellular dermal matrix treated according to Example 3 with dimensions of 2 cm x 6 cm or 12 cm2 is placed on a table. The desired quantity of P4HB being 0.0164 g / cm2, an 18% (w / w) P4HB / acetone solution is prepared. The necessary quantity is taken and deposited on the implant. The casting knife is then moved by translation on the implant in order to standardize the thickness of the coating. In order to automate the operation, a coating machine can be used. An acetone / P4HB solution is prepared to feed the machine. The solution is pumped through a slot die to be applied to the moving flat biological implant. In a preferred embodiment, the width of the slot die is 600 mm, the implant progression speed is 1 - 10 m / min. The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0097] Example 8: Example of a dip coating process An acellular biological matrix treated according to Example 4 of 4 cm x 6 cm is immersed by a machine (the implant is placed on a vertical crossbar) in a tank containing an acetone / P4HB solution at the desired concentration. The biological matrix is ​​then extracted from the tank by an upward vertical movement at a speed of 25 mm / min. The density of P4HB obtained by the coating is then 0.02 to 0.04 g / cm2. The parameters (size of the part to be treated, speed of the crossbar, concentration of the solution) are understandable by those skilled in the art in order to obtain the coating desired in the end. The matrix is ​​then wetted and shaped according to one of examples 1 or 2. The matrix is ​​then preferably dried so as to have a residual humidity level of between 10% and 18%.

[0098] Example 9: example of drying and pressing and characteristics of the devices medical obtained A dermal matrix treated according to Example 3 is coated with approximately 0.03g / cm2 of P4HB and is pressed for 30s at 100 bars of pressure and 50°C (pre-heated press plate). On 3 specimens tested, with an average thickness of 1.35 mm, the average max uniaxial tensile strength (UTS) is 26.50 MPa.

[0099] The test is carried out on an Instron model 3342 / L2345 measuring bench. The specimen is cut with a bone shape type V cutter as described in the ASTM D-638-5 standard. The piece thus cut is introduced from each end into the pneumatic jaws of the bench (60 psi) leaving a central part of 2.5 cm. A speed of 25 mm / min is applied until the piece breaks. The uniaxial tensile strength is reported (max. force / sectional area). A T-peel test is performed. 2 cm x 6 cm specimens are cut. The P4HB coating is separated from the biological implant over a 1.5 cm x 2 cm section. The 2 separated pieces are placed in the pneumatic jaws (45 psi). The coated section of the biological implant is separated at a speed of 25 mm / min. The T-peel force is measured over a standardized width of 20 mm and an average of 5 peaks (loads). On the 3 specimens tested, the adhesion was stronger so that the test did not peel the coated layer.

[0100] Example 10: example of drying and pressing and characteristics of the medical devices obtained

[0101] According to the same previous test conditions, a dermal matrix treated according to example 4 is coated with approximately 0.03 g / cm2 of P4HB then pressed for 60 s at 200 bar and 100°C. An average UTS max value of 27.65 MPa is obtained on 3 test pieces.

[0102] Example 11:

[0103] According to the same previous test conditions, a dermal matrix treated according to example 5 is coated with approximately 0.03 g / cm2 of P4HB then pressed for 30 s at 100 bar and 100°C. An average UTS max value of 33.07 MPa is obtained on 3 test pieces.

Claims

Claims

1. Method for manufacturing a three-dimensional medical device from an acellular biological matrix characterized in that it comprises at least the succession of the following steps: a / wetting an acellular biological matrix with a liquid, and b / shaping the wetted acellular biological matrix so that it takes a three-dimensional shape.

2. Method of manufacturing a medical device according to claim 1, characterized in that step a / consisting of wetting the acellular biological matrix is ​​carried out by soaking the acellular biological matrix in a volume of water allowing its immersion.

3. Method of manufacturing a medical device according to the preceding claim, characterized in that the soaking is carried out for a period of 30 seconds to 20 minutes.

4. Method of manufacturing a medical device according to one of the preceding claims, characterized in that step a / is carried out with pyrogen-free water.

5. Method of manufacturing a medical device according to one of the preceding claims, characterized in that step a / is carried out so as to obtain an acellular biological matrix of gray color.

6. Method of manufacturing a medical device according to one of the preceding claims, characterized in that step b / of shaping is carried out by vacuum forming and / or wet molding and / or pressing.

7. Method of manufacturing a medical device according to one of the preceding claims, characterized in that the acellular biological matrix is ​​of human or animal origin.

8. Method of manufacturing a medical device according to the preceding claim, characterized in that the acellular biological matrix of animal origin is chosen from acellular biological matrices of porcine, bovine, equine, caprine, fish origin and their mixtures.

9. Method of manufacturing a medical device according to one of the preceding claims, characterized in that the acellular biological matrix is ​​chosen from one of the following biological matrices: dermis, intestinal submucosa, aorta, bladder, amniotic membrane, peritoneum, pericardium, dura mater, tendons, cartilage and mixtures thereof.

10. Method for manufacturing a medical device according to one of the preceding claims, characterized in that it comprises: - before or after step a / or before or after step b / , a step of preparing the acellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, and - before or after step a / or before or after step b / , and after the step of preparing the acellular biological matrix, a step of partially or totally coating the acellular biological matrix with a solution comprising at least one polymer.

11. Method of manufacturing a medical device according to the preceding claim, characterized in that the coating is carried out at a temperature lower than or equal to the denaturation temperature of the collagen.

12. Method of manufacturing a medical device according to the preceding claim, characterized in that the coating is carried out at a temperature between 10 and 60°C.

13. Method of manufacturing a medical device according to one of claims 10 to 12, characterized in that before coating and / or after coating, the acellular biological matrix is ​​dried so as to have a residual humidity level of between 10% and 18%.

14. Method of manufacturing a medical device according to one of claims 10 to 13, characterized in that the step of preparing the wetted cellular biological matrix so as to allow adhesion to said acellular biological matrix of a solution comprising at least one polymer, consists of a chemical and / or mechanical and / or electrochemical and / or physical surface treatment.

15. Method of manufacturing a medical device according to one of claims 10 to 14, characterized in that the coating is carried out by casting coating, spray coating or immersion coating.

16. Method of manufacturing a medical device according to one of claims 10 to 15, characterized in that the solution comprising at least one polymer has been previously obtained by solubilization of the polymer(s) in at least one polar solvent.

17. Method of manufacturing a medical device according to the preceding claim, characterized in that after solubilization of the polymer(s), the solution is degassed and / or debubbled under vacuum to purge the mixture of air bubbles.

18. Method for manufacturing a medical device according to one of claims 10 to 17, characterized in that the solution of polymer(s) comprises one or more polymers chosen from the following polymers: poly-hydroxyalkanoates, poly(glycolides), poly(lactide-co-glycolides), poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acids), polycaprolactones, poly(orthoesters), polyanhydrides, poly(phosphazenes), polyhydroxyalkanoates, polyesters, poly(lactide-co-caprolactones), polycarbonates; tyrosine polycarbonates, polyamides, polyesteramides, poly(dioxanones), poly(alkylene alkylates), polyethers, polyvinyl pyrrolidones, polyurethanes, poly-etheresters, polyacetals, polycyanoacrylates, poly(oxyethylene), poly(oxypropylene) copolymers, polyacetals, polyketals, poly-phosphates, polyphosphoesters, polyalkylene oxalates, polyalkylene succinates, poly(maleic acids), chitin, chitosan, and mixtures thereof.

19. Method of manufacturing a medical device according to one of claims 10 to 18, characterized in that the solution of polymer(s) comprises at least P4HB solubilized in an acetone solution.

20. Three-dimensional medical device capable of being obtained by implementing the method according to one of claims 1 to 19, characterized in that it comprises at least one acellular biological matrix shaped in three dimensions.

21. Three-dimensional medical device according to the preceding claim, characterized in that it does not comprise a support for maintaining the biological matrix in three dimensions.

22. Three-dimensional medical device according to claim 20 or 21, characterized in that the three-dimensionally shaped acellular biological matrix is ​​partially or totally covered by at least one layer comprising at least one polymer.

23. Three-dimensional medical device according to claim 22, characterized in that it is an implant for breast reconstruction.